Trial NCT00800150

View at ClinicalTrials.gov 
Org. Study IDs: 08076
Secondary IDs: CDR0000626148 CHNMC-08076 P30CA033572

Last trial update was posted on 2015-06-08

MeSH Interventions

Fludarabine Fludarabine phosphate Melphalan

MeSH Conditions

Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myelodysplastic-Myeloproliferative Diseases Myeloproliferative Disorders Neoplasms Neoplasms, Plasma Cell Plasmacytoma Preleukemia Syndrome

Other Conditions

Chronic Myeloproliferative Disorders Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic/Myeloproliferative Neoplasms

Stopping Reasons

Protocol objective could not be met. A new study with amended eligibility criteria will be developed.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID